Year All20262025202420232022 August 10, 2026 Ceribell Reports Second Quarter 2026 Financial Results August 10, 2026 Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review August 3, 2026 Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System July 29, 2026 Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe July 28, 2026 Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference July 20, 2026 Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026 June 8, 2026 Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes May 20, 2026 Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference May 11, 2026 Ceribell Reports First Quarter 2026 Financial Results April 29, 2026 Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
August 10, 2026 Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
August 3, 2026 Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
July 29, 2026 Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
June 8, 2026 Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
